Series A Funded Health Care Startups
Among the 50 listed Series A health care rounds with disclosed amounts, the largest disclosed round is PhaseV at $50M on 2025-05-13; the next-highest discl…
Among the 50 listed Series A health care rounds with disclosed amounts, the largest disclosed round is PhaseV at $50M on 2025-05-13; the next-highest disclosed levels cluster in the $44M–$33M range (Ellipsis Health at $44M on 2025-05-01 and Syntis Bio at $33M on 2025-07-01, General Medicine at $32M on 2025-05-22, and ExaCare at $30M on 2025-10-13). At the low end, Little Journey closed at just $400K on 2025-07-17, creating a wide spread from the smallest disclosed round to the top of the table.
Geographically, California appears repeatedly: multiple entries are based in San Francisco (e.g., Rhythm Diagnostic Systems on 2025-10-01 for $16M; Daymark Health on 2025-09-28 for $20M; Charta Health on 2025-07-22 for $22M), and Los Angeles shows up more than once (Axle Health on 2025-05-22 for $10M; Superpower on 2025-04-22 for $30M; Cofertility on 2025-04-10 for $7M). Temporally, the newest round in the dataset is NextSense on 2025-11-12 for $16M, while the oldest shown is VerAvanti on 2025-03-11 for $28M. Out of 50 rows, 4 rounds are undisclosed (Oryl Photonics on 2025-09-09, Prosoma on 2025-06-16, AlfaDocs on 2025-05-14, and Idana on 2025-03-19), with the outliers in disclosed size still visible across the disclosed-only range (e.g., ForCast Orthopedics at $4M on 2025-08-05; Healthera at $3M on 2025-04-16).
Most recent rounds
50 shownRelated listings
Frequently asked
What does the largest disclosed Series A round in this list look like relative to the others?
PhaseV’s $50M (2025-05-13) is the only disclosed round above $44M in the table; the next tier is $44M down to $33M, including Ellipsis Health at $44M (2025-05-01) and Syntis Bio at $33M (2025-07-01).
Are there timing clusters where multiple Series A rounds hit within a short window?
Yes. Several rounds land in late May 2025, including General Medicine at $32M (2025-05-22), PhaseV at $50M (2025-05-13), Ellipsis Health at $44M (2025-05-01), and multiple $8M rounds around 2025-05-13–2025-05-14 (e.g., Passage Health $8M on 2025-05-13; Surgify $8M on 2025-05-27).
Which geographies are over-represented, and where do the biggest disclosed rounds show up?
California appears repeatedly, with multiple San Francisco rounds (Rhythm Diagnostic Systems $16M on 2025-10-01; Daymark Health $20M on 2025-09-28; Charta Health $22M on 2025-07-22) and multiple Los Angeles rounds (Axle Health $10M on 2025-05-22; Superpower $30M on 2025-04-22; Cofertility $7M on 2025-04-10).
How often are amounts missing, and do undisclosed rounds affect the size-range interpretation?
4 of 50 rows are undisclosed (Oryl Photonics 2025-09-09; Prosoma 2025-06-16; AlfaDocs 2025-05-14; Idana 2025-03-19). Among disclosed rounds, the spread is still wide: Little Journey is $400K (2025-07-17) while PhaseV is $50M (2025-05-13).
Which entries represent major low-end outliers within disclosed amounts?
Several sub-$5M rounds stand out: Healthera closed at $3M (2025-04-16), ForCast Orthopedics at $4M (2025-08-05), and Cupron at $4M (2025-03-26), contrasting with multiple entries in the $20M–$30M band such as Foundation Health $20M (2025-10-12) and ExaCare $30M (2025-10-13).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.